 | • レポートコード：MRC2-11QY04163 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はパーキンソン病治療のグローバル市場について調査・分析したレポートです。種類別（レボドパ/カルビドパ、ドーパミン受容体作動薬、MAO阻害剤、COMT阻害剤、抗コリン作用薬）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別パーキンソン病治療の競争状況、市場シェア ・世界のパーキンソン病治療市場：種類別市場規模 2015年-2020年（レボドパ/カルビドパ、ドーパミン受容体作動薬、MAO阻害剤、COMT阻害剤、抗コリン作用薬） ・世界のパーキンソン病治療市場：種類別市場規模予測 2021年-2026年（レボドパ/カルビドパ、ドーパミン受容体作動薬、MAO阻害剤、COMT阻害剤、抗コリン作用薬） ・世界のパーキンソン病治療市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界のパーキンソン病治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米のパーキンソン病治療市場分析：米国、カナダ ・ヨーロッパのパーキンソン病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのパーキンソン病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のパーキンソン病治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのパーキンソン病治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GSK、Merck、Novartis、Teva、Boehringer Ingelheim、Impax、Abbvie、Bausch Health、Lundbeck、Sun Pharmaceutical Industries、Wockhardt、Acadia Pharmaceuticals、UCB ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Parkinson’s disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.
There is no cure for Parkinson’s disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA), with dopamine agonistsbeing used once levodopa becomes less effective. As the disease progresses and neurons continue to be lost, these medications become less effective while at the same time they produce a complication marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at improving symptoms.
Market Analysis and Insights: Global Parkinson’s Disease Treatment Market
The global Parkinson’s Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Parkinson’s Disease Treatment Scope and Market Size
Parkinson’s Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson’s Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GSK
Merck
Novartis
Teva
Boehringer Ingelheim
Impax
Abbvie
Bausch Health
Lundbeck
Sun Pharmaceutical Industries
Wockhardt
Acadia Pharmaceuticals
UCB
Market segment by Type, the product can be split into
Levodopa/carbidopa
Dopamine Receptor Agonists
MAO-Inhibitors
COMT-inhibitors
Anticholinergics
Market segment by Application, split into
Hospitals
Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Parkinson’s Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Parkinson’s Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Levodopa/carbidopa
1.4.3 Dopamine Receptor Agonists
1.4.4 MAO-Inhibitors
1.4.5 COMT-inhibitors
1.4.6 Anticholinergics
1.5 Market by Application
1.5.1 Global Parkinson’s Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Parkinson’s Disease Treatment Market Perspective (2015-2026)
2.2 Global Parkinson’s Disease Treatment Growth Trends by Regions
2.2.1 Parkinson’s Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Parkinson’s Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Parkinson’s Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Parkinson’s Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Parkinson’s Disease Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Parkinson’s Disease Treatment Players by Market Size
3.1.1 Global Top Parkinson’s Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Parkinson’s Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Parkinson’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Parkinson’s Disease Treatment Market Concentration Ratio
3.2.1 Global Parkinson’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Treatment Revenue in 2019
3.3 Parkinson’s Disease Treatment Key Players Head office and Area Served
3.4 Key Players Parkinson’s Disease Treatment Product Solution and Service
3.5 Date of Enter into Parkinson’s Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Parkinson’s Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Parkinson’s Disease Treatment Market Size by Application (2015-2020)
5.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Parkinson’s Disease Treatment Market Size (2015-2020)
6.2 Parkinson’s Disease Treatment Key Players in North America (2019-2020)
6.3 North America Parkinson’s Disease Treatment Market Size by Type (2015-2020)
6.4 North America Parkinson’s Disease Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Parkinson’s Disease Treatment Market Size (2015-2020)
7.2 Parkinson’s Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Parkinson’s Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Parkinson’s Disease Treatment Market Size by Application (2015-2020)
8 China
8.1 China Parkinson’s Disease Treatment Market Size (2015-2020)
8.2 Parkinson’s Disease Treatment Key Players in China (2019-2020)
8.3 China Parkinson’s Disease Treatment Market Size by Type (2015-2020)
8.4 China Parkinson’s Disease Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Parkinson’s Disease Treatment Market Size (2015-2020)
9.2 Parkinson’s Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Parkinson’s Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Parkinson’s Disease Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Parkinson’s Disease Treatment Market Size (2015-2020)
10.2 Parkinson’s Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Parkinson’s Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Parkinson’s Disease Treatment Market Size by Application (2015-2020)
11 India
11.1 India Parkinson’s Disease Treatment Market Size (2015-2020)
11.2 Parkinson’s Disease Treatment Key Players in India (2019-2020)
11.3 India Parkinson’s Disease Treatment Market Size by Type (2015-2020)
11.4 India Parkinson’s Disease Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Parkinson’s Disease Treatment Market Size (2015-2020)
12.2 Parkinson’s Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Parkinson’s Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Parkinson’s Disease Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GSK
13.1.1 GSK Company Details
13.1.2 GSK Business Overview
13.1.3 GSK Parkinson’s Disease Treatment Introduction
13.1.4 GSK Revenue in Parkinson’s Disease Treatment Business (2015-2020))
13.1.5 GSK Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Parkinson’s Disease Treatment Introduction
13.2.4 Merck Revenue in Parkinson’s Disease Treatment Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Parkinson’s Disease Treatment Introduction
13.3.4 Novartis Revenue in Parkinson’s Disease Treatment Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Teva
13.4.1 Teva Company Details
13.4.2 Teva Business Overview
13.4.3 Teva Parkinson’s Disease Treatment Introduction
13.4.4 Teva Revenue in Parkinson’s Disease Treatment Business (2015-2020)
13.4.5 Teva Recent Development
13.5 Boehringer Ingelheim
13.5.1 Boehringer Ingelheim Company Details
13.5.2 Boehringer Ingelheim Business Overview
13.5.3 Boehringer Ingelheim Parkinson’s Disease Treatment Introduction
13.5.4 Boehringer Ingelheim Revenue in Parkinson’s Disease Treatment Business (2015-2020)
13.5.5 Boehringer Ingelheim Recent Development
13.6 Impax
13.6.1 Impax Company Details
13.6.2 Impax Business Overview
13.6.3 Impax Parkinson’s Disease Treatment Introduction
13.6.4 Impax Revenue in Parkinson’s Disease Treatment Business (2015-2020)
13.6.5 Impax Recent Development
13.7 Abbvie
13.7.1 Abbvie Company Details
13.7.2 Abbvie Business Overview
13.7.3 Abbvie Parkinson’s Disease Treatment Introduction
13.7.4 Abbvie Revenue in Parkinson’s Disease Treatment Business (2015-2020)
13.7.5 Abbvie Recent Development
13.8 Bausch Health
13.8.1 Bausch Health Company Details
13.8.2 Bausch Health Business Overview
13.8.3 Bausch Health Parkinson’s Disease Treatment Introduction
13.8.4 Bausch Health Revenue in Parkinson’s Disease Treatment Business (2015-2020)
13.8.5 Bausch Health Recent Development
13.9 Lundbeck
13.9.1 Lundbeck Company Details
13.9.2 Lundbeck Business Overview
13.9.3 Lundbeck Parkinson’s Disease Treatment Introduction
13.9.4 Lundbeck Revenue in Parkinson’s Disease Treatment Business (2015-2020)
13.9.5 Lundbeck Recent Development
13.10 Sun Pharmaceutical Industries
13.10.1 Sun Pharmaceutical Industries Company Details
13.10.2 Sun Pharmaceutical Industries Business Overview
13.10.3 Sun Pharmaceutical Industries Parkinson’s Disease Treatment Introduction
13.10.4 Sun Pharmaceutical Industries Revenue in Parkinson’s Disease Treatment Business (2015-2020)
13.10.5 Sun Pharmaceutical Industries Recent Development
13.11 Wockhardt
10.11.1 Wockhardt Company Details
10.11.2 Wockhardt Business Overview
10.11.3 Wockhardt Parkinson’s Disease Treatment Introduction
10.11.4 Wockhardt Revenue in Parkinson’s Disease Treatment Business (2015-2020)
10.11.5 Wockhardt Recent Development
13.12 Acadia Pharmaceuticals
10.12.1 Acadia Pharmaceuticals Company Details
10.12.2 Acadia Pharmaceuticals Business Overview
10.12.3 Acadia Pharmaceuticals Parkinson’s Disease Treatment Introduction
10.12.4 Acadia Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2015-2020)
10.12.5 Acadia Pharmaceuticals Recent Development
13.13 UCB
10.13.1 UCB Company Details
10.13.2 UCB Business Overview
10.13.3 UCB Parkinson’s Disease Treatment Introduction
10.13.4 UCB Revenue in Parkinson’s Disease Treatment Business (2015-2020)
10.13.5 UCB Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Parkinson's Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Parkinson's Disease Treatment Revenue
Table 3. Ranking of Global Top Parkinson's Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Parkinson's Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Levodopa/carbidopa
Table 6. Key Players of Dopamine Receptor Agonists
Table 7. Key Players of MAO-Inhibitors
Table 8. Key Players of COMT-inhibitors
Table 9. Key Players of Anticholinergics
Table 10. Global Parkinson's Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Parkinson's Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Parkinson's Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Parkinson's Disease Treatment Market Share by Regions (2015-2020)
Table 14. Global Parkinson's Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Parkinson's Disease Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Parkinson's Disease Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Parkinson's Disease Treatment Players
Table 21. Global Parkinson's Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Parkinson's Disease Treatment Market Share by Players (2015-2020)
Table 23. Global Top Parkinson's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Treatment as of 2019)
Table 24. Global Parkinson's Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Parkinson's Disease Treatment Product Solution and Service
Table 27. Date of Enter into Parkinson's Disease Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Parkinson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Parkinson's Disease Treatment Market Size Share by Type (2015-2020)
Table 31. Global Parkinson's Disease Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Parkinson's Disease Treatment Market Size Share by Application (2015-2020)
Table 33. Global Parkinson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Parkinson's Disease Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Parkinson's Disease Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Parkinson's Disease Treatment Market Share (2019-2020)
Table 37. North America Parkinson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Parkinson's Disease Treatment Market Share by Type (2015-2020)
Table 39. North America Parkinson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Parkinson's Disease Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Parkinson's Disease Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Parkinson's Disease Treatment Market Share (2019-2020)
Table 43. Europe Parkinson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Parkinson's Disease Treatment Market Share by Type (2015-2020)
Table 45. Europe Parkinson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Parkinson's Disease Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Parkinson's Disease Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Parkinson's Disease Treatment Market Share (2019-2020)
Table 49. China Parkinson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Parkinson's Disease Treatment Market Share by Type (2015-2020)
Table 51. China Parkinson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Parkinson's Disease Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Parkinson's Disease Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Parkinson's Disease Treatment Market Share (2019-2020)
Table 55. Japan Parkinson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Parkinson's Disease Treatment Market Share by Type (2015-2020)
Table 57. Japan Parkinson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Parkinson's Disease Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Parkinson's Disease Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Parkinson's Disease Treatment Market Share (2019-2020)
Table 61. Southeast Asia Parkinson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Parkinson's Disease Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Parkinson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Parkinson's Disease Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Parkinson's Disease Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Parkinson's Disease Treatment Market Share (2019-2020)
Table 67. India Parkinson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Parkinson's Disease Treatment Market Share by Type (2015-2020)
Table 69. India Parkinson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Parkinson's Disease Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Parkinson's Disease Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Parkinson's Disease Treatment Market Share (2019-2020)
Table 73. Central & South America Parkinson's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Parkinson's Disease Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Parkinson's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Parkinson's Disease Treatment Market Share by Application (2015-2020)
Table 77. GSK Company Details
Table 78. GSK Business Overview
Table 79. GSK Product
Table 80. GSK Revenue in Parkinson's Disease Treatment Business (2015-2020) (Million US$)
Table 81. GSK Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Product
Table 85. Merck Revenue in Parkinson's Disease Treatment Business (2015-2020) (Million US$)
Table 86. Merck Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Product
Table 90. Novartis Revenue in Parkinson's Disease Treatment Business (2015-2020) (Million US$)
Table 91. Novartis Recent Development
Table 92. Teva Company Details
Table 93. Teva Business Overview
Table 94. Teva Product
Table 95. Teva Revenue in Parkinson's Disease Treatment Business (2015-2020) (Million US$)
Table 96. Teva Recent Development
Table 97. Boehringer Ingelheim Company Details
Table 98. Boehringer Ingelheim Business Overview
Table 99. Boehringer Ingelheim Product
Table 100. Boehringer Ingelheim Revenue in Parkinson's Disease Treatment Business (2015-2020) (Million US$)
Table 101. Boehringer Ingelheim Recent Development
Table 102. Impax Company Details
Table 103. Impax Business Overview
Table 104. Impax Product
Table 105. Impax Revenue in Parkinson's Disease Treatment Business (2015-2020) (Million US$)
Table 106. Impax Recent Development
Table 107. Abbvie Company Details
Table 108. Abbvie Business Overview
Table 109. Abbvie Product
Table 110. Abbvie Revenue in Parkinson's Disease Treatment Business (2015-2020) (Million US$)
Table 111. Abbvie Recent Development
Table 112. Bausch Health Business Overview
Table 113. Bausch Health Product
Table 114. Bausch Health Company Details
Table 115. Bausch Health Revenue in Parkinson's Disease Treatment Business (2015-2020) (Million US$)
Table 116. Bausch Health Recent Development
Table 117. Lundbeck Company Details
Table 118. Lundbeck Business Overview
Table 119. Lundbeck Product
Table 120. Lundbeck Revenue in Parkinson's Disease Treatment Business (2015-2020) (Million US$)
Table 121. Lundbeck Recent Development
Table 122. Sun Pharmaceutical Industries Company Details
Table 123. Sun Pharmaceutical Industries Business Overview
Table 124. Sun Pharmaceutical Industries Product
Table 125. Sun Pharmaceutical Industries Revenue in Parkinson's Disease Treatment Business (2015-2020) (Million US$)
Table 126. Sun Pharmaceutical Industries Recent Development
Table 127. Wockhardt Company Details
Table 128. Wockhardt Business Overview
Table 129. Wockhardt Product
Table 130. Wockhardt Revenue in Parkinson's Disease Treatment Business (2015-2020) (Million US$)
Table 131. Wockhardt Recent Development
Table 132. Acadia Pharmaceuticals Company Details
Table 133. Acadia Pharmaceuticals Business Overview
Table 134. Acadia Pharmaceuticals Product
Table 135. Acadia Pharmaceuticals Revenue in Parkinson's Disease Treatment Business (2015-2020) (Million US$)
Table 136. Acadia Pharmaceuticals Recent Development
Table 137. UCB Company Details
Table 138. UCB Business Overview
Table 139. UCB Product
Table 140. UCB Revenue in Parkinson's Disease Treatment Business (2015-2020) (Million US$)
Table 141. UCB Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson's Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Levodopa/carbidopa Features
Figure 3. Dopamine Receptor Agonists Features
Figure 4. MAO-Inhibitors Features
Figure 5. COMT-inhibitors Features
Figure 6. Anticholinergics Features
Figure 7. Global Parkinson's Disease Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Parkinson's Disease Treatment Report Years Considered
Figure 11. Global Parkinson's Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Parkinson's Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Parkinson's Disease Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Parkinson's Disease Treatment Market Share by Players in 2019
Figure 16. Global Top Parkinson's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Parkinson's Disease Treatment Revenue in 2019
Figure 18. North America Parkinson's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Parkinson's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Parkinson's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Parkinson's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Parkinson's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Parkinson's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Parkinson's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
パーキンソン病の世界市場（～2026年） Market Analysis and Insights: Global Parkinson's Disease Market The global Parkinson's Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Parkinson's Disease Scope and Market Size Parkinson's Disease market is seg…- ウォルフパーキンソンホワイト症候群治療の世界市場（～2026年） Wolff-Parkinson-White (WPW) syndrome is a rare congenital heart disorder involving irregularities in the electrical transmission system of the heart. In WPW syndrome, an abnormal alternate electrical pathway exists resulting in arrhythmias (abnormal heartbeat rhythms) and tachycardia (faster than no…
- パーキンソン病（PD）治療薬の世界市場（～2026年） Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by damage to the dopaminergic neurons located in various parts of the brain, including the substantia nigra. The emergence of gene therapy to reverse the progression of PD is one of the key trends that will gain tract…
- クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- ニューカッスル病治療の世界市場（～2026年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…